2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Face Pareidolia in the East London Parkinson’s Disease Project

E. Camboe, KC. Dey, A. Zirra, S. Waters, E. Bhadra, R. Laban, B. Huxford, C. Simonet, C. Budu, DA. Gallagher, V. Azoidou, T. Boyle, C. Cooper, AJ. Noyce (London, United Kingdom)
Factors Associated with Efficacy and Safety of Unilateral Thalamic MRgFUS in Essential Tremor: A Single-Center Cohort Study

M. Gea, L. Ispierto, M. Tardáguila, A. Gonzalez, J. Muñoz, R. García, J. Ríos, C. Villa, R. álvarez, D. Vilas (Badalona, Spain)
Factors Influencing Participation in Genetic Testing Among Prodromal and Family History Positive Controls in Parkinson’s Disease Genetic Cohort in Thailand

K. Horaruengdecha, J. Sringean, S. Maytharakcheep, R. Bhidayasiri, P. Panyakaew (Bangkok, Thailand)
Factors Influencing Participation in Genetic Testing in Parkinson’s Disease Genetic Cohort in Thailand: Patients and Neurologists Perspective

R. Seeluangsawat, K. Horaruengdecha, J. Sringean, R. Bhidayasiri, P. Panyakaew (Bangkok, Thailand)
Familial Myoclonus-Dystonia Associated with SGCE Variant in a Chinese Family: Clinical and Genetic Characterization of Two Siblings

G. Xing (Guang Zhou, China)
Family Caregivers and eHealth in Parkinson’s Disease: Insights From a Qualitative Study

H. Johansson, A. Alvariza, B. Leavy (Stockholm, Sweden)
FDG-PET-Based Machine Learning Differentiates Parkinson’s Disease from Other Neurodegenerative Disorders

B. Song, P. Turcano, K. Ghoniem, C. Piat, E. Camerucci, J. Bower, L. Barnard, D. Jones, R. Savica (Rochester, USA)
Fear Across the Disease Course: How Age, Sex, and Disease Duration Influence Different Types of Fear in Parkinson’s Disease

A. Babarinde, R. Duncan, J. Longhurst, M. Landers (St Louis, USA)
Feasibility and Preliminary Outcomes of an Online Fatigue Self Management Programme for People With Parkinsons Disease

SA. Alageel, KD. Deane, JH. Hibberd (Riyadh, Saudi Arabia)
Feasibility of home-based assessments using wearable sensors and videos in children with GNAO1-related movement disorders: A pilot study

L. Heideman, J. Boor, L. Al-Bawi, N. Wolf, A. Buizer, H. Haberfehlner, L. Vande Pol (Amsterdam, Netherlands)
Feasibility of Remote Identification of Catatonia Across Different Motor Presentations

N. Kadubandi, A. Elshourbagy, A. Tasmiya, M. van Emdeboas, R. Aydin, A. Epstein, R. Guo, L. Smith, N. Li, J. Barnett, J. Brasic (Baltimore, USA)
Feasibility of the ActivPARK Study – Longitudinal Assessment of Physical Activity in People with Parkinson’s Disease

E. Franzén, L. Sandberg, M. Nilsson, F. Bergquist, G. Johansson, S. Guidetti, M. Hagströmer, EL. Jansson, D. Conradsson, G. Faxen Irving, S. Ljungblom, F. Albrecht, C. Joseph (Stockholm, Sweden)
Feasibility study of a portable medical device, the Neuromotor pen, as a screening tool for Parkinson’s disease in a rural northern Tanzania

I. Terry, T. Neal, R. Haggie, W. Eliamini, S. Linus, M. Dekker, S. Urasa, D. Mushi, R. Zietsma, D. Bramwell, C. Papasavvas, C. Nye, R. Walker, C. Dotchin (Newcastle, United Kingdom)
Ferritin as a factor in the examination of Parkinson’s disease and Progressive Supranuclear Palsy

P. Alster, M. Markiewicz, P. Chunowski, N. Madetko-Alster (Warsaw, Poland)
Festinating Speech in Parkinson’s Disease: Effects of Deep-Brain Stimulation and Interspeaker Variability

Y. Kim, I. Nip, C. Venter, E. Urrea-Mendoza (Tallahassee, USA)
Fibrinogen and CFAH as putative biomarkers for Parkinson’s disease

P. Alladi, S. Choudhury, R. Bhavani, NC. Krithika, K. Krishnakumari, H. Jyothi, A. Mahadevan, P. Pal, V. Holla, S. Hegde, N. Kamble, R. Yadav (Bengaluru, India)
Fine-Mapping Genetic Risk and Age at Onset Loci in Parkinson’s Disease

S. Jasaitytė, L. Gilchrist, GP2. Genetics Program, A. Noyce, P. Proitsi, K. Brolin, MT. Periñan (London, United Kingdom)
First Reported Experience of Dual Therapy With Deep Brain Stimulation and Foslevodopa/Foscarbidopa Subcutaneous Infusion

E. Casas, I. Muro, P. Lorenzo, L. Lopez-Manzanares (Madrid, Spain)
First-in-Human Single-Ascending-Dose Trial of ALN-SNCA, an Intrathecally Administered siRNA for Reducing α-synuclein, in Patients with Early-Stage Parkinson’s Disease

M. Ahmed, M. Effendi, S. Schneider, M. Rosario, M. Magliocca, A. Gorbenko, B. Bugna, L. Farrelly, P. Kremer, R. Postuma, J. Whitton, A. Avbersek, O. Harari (Tarrytown, USA)
Five-Year Real-World Outcomes Of Botulinum Toxin Injections For Sialorrhoea In Parkinson’s

R. Biju, B. Mohamed, J. Adenwalla, C. Thomas, S. Aviet (Cardiff, United Kingdom)
Five‑Year Outcomes Following Unilateral MR‑Guided Focused Ultrasound Pallidotomy in Parkinson’s Disease

A. Fasano, A. Sokolov, K. Gant, A. Grinspan (Toronto, Canada)
Fluid Biomarker Signatures in Atypical Parkinsonian Syndromes: Insights into Neurodegeneration and Clinical Heterogeneity

R. Yadav, R. Kumar, S. Dey, A. K, G. Tv, M. Harish, V. Holla, R. Mahale, N. Kamble, P. Mailankody, A. Mehta, M. Debnath, S. Subramanian, P. Pal (Bengaluru, India)
Fluid Biomarkers and the 4R-Tauopathies

C. Fogliano, ML. Nasi, S. Cauzzo, R. Manara, F. Pistonesi, E. Fiorenzato, M. Carecchio, W. Meissner, R. Biundo, M. Campagnolo, A. Antonini (Padova, Italy)
fMRI Activity during Working Memory Manipulation is Associated with Caudate Integrity in Early Parkinson’s Disease

K. Giehl, H. Theis, A. Asendorf, M. Banwinkler, V. Dzialas, R. Lubomierski, M. Hönig, T. van Eimeren (Juelich, Germany)
Focused Ultrasound for Essential Tremor: Results After One Year

V. Hvingelby, P. Kjeldsen, B. Bergholt, G. Schechtmann, E. Danielsen, M. Møller, S. Mardosiene, T. Lund, D. Grauballe, M. Geneser, L. Bak, P. Wied, H. Zaer, K. Meier, B. Jespersen, C. Eriksen, C. Bræmer-Madsen, N. Pavese, JC. Sørensen, A. Glud (Aarhus N, Denmark)
Foslevodopa-Foscarbidopa Continuous Subcutaneous Infusion Leads to Long-Term Reduction in Dyskinesia in Parkinson’s Disease: Results from 5-Year Follow-Up

N. Jeyakumar, P. Becker, M. Georgiades, D. Tsui, X. Chen, S. Bray, J. Qiu, S. Waller, L. Williams, S. Dal, T. Ong, A. Martin, H. Morales-Briceno, V. Fung (Sydney, Australia)
Fracture Burden and Health-Related Quality of Life in Older Adults with Parkinson’s Disease in Rural India: A Community-Based Study

B. Kuanar, D. Panda (Bhubaneswar, India)
Framework for Future Neurology Trials: Enhanced Scientific Rigor Through Innovative Decentralized Trial Methodology

M. Souza, M. Sniecinski, C. Santos, M. Giroux, M. Steidle, R. Elble, CA. Cooper, A. Fasano, A. Shtilbans, J. Farmer, S. Brillman (Boston, USA)
Freezing of Gait in Atypical Parkinsonism improves with Transcranial Direct Current Stimulation

S. Ray, G. Sarma, A. Sharma (Bangalore, India)
Frequency and Phenotypic Characterization of Genetic Causes of Sporadic Late-Onset Cerebellar Ataxia: insights from a Cohort of 315 patients

M. Barrat, T. Wirth (Dijon, France)
Frequency-Dependent Disruption of Head-Trunk Control in Cervical Dystonia

T. Hart, L. Heideman, A. Sadnicka, F. Morgante (London, United Kingdom)
Frequency-Specific Effects of SMA-rTMS on Gait Initiation in Parkinson’s Disease

Y. Chen, Y. Wang, Y. Wang, J. Jiang, C. Xu, F. Chung, M. Pang, M. Mak, M. Huang (Kowloon, Hong Kong)
From Cerebral Palsy to GNAO1-Related Movement Disorder: An Adult Diagnosis with Marked Response to Pallidal Deep Brain Stimulation

S. Antigua-Jimenez, M. Situ-Kcomt, M. Seier (Omaha, USA)
From Clinic to Home: Transitioning a Reduced Wearable Sensor Monitoring Array in Parkinson’s Disease

N. Conway, C. Sotirakis, A. D'Souza, P. Ginis, V. Shah, C. Antoniades (University of Oxford, United Kingdom)
From Clinical Patterns to Symptom-specific Functional Networks in Dyskinetic Cerebral Palsy

AL. Almeida Marcelino, B. Al-Fatly, L. de Pol, M. Tuncer, NM. Wilpert, A. Tietze, C. Werner, A. Saryyeva, M. San Luciano, L. Timmermann, A. Schnitzler, J. Krauss, P. Starr, A. Kaindl, A. Koy, A. Buizer, A. Kühn (Berlin, Germany)
From Down Under to a Global Audience: Engaging 25,000 People Across 160 Countries to Improve Parkinson’s Knowledge and Awareness

J. Alty, E. Handley, S. Bramich, H. Stanton, A. Noyce, T. Saunder, A. Kitsos, C. Parker, M. Callisaya (Hobart, Australia)
From Hysteria to Functional Movement Disorders: The Evolution of a Concept

L. Ali, N. Kouki, N. Kouki (Camerino, Italy)
From Roots to Relief: A Systematic Review of Herbal Medicines in Parkinson’s Management

N. Sukmueng, O. Phokeawvarangkul, R. Bhidayasiri (Bangkok, Thailand)
From Vision to Reality: Nursing Driven Implementation, Policy, and Safety Framework for Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in a Tertiary Movement Disorder Centre

E. de Freitas, S. Mittal (Abu Dhabi, United Arab Emirates)
Frontal Cortical Reactivity Underlying Cue Responsiveness in Parkinson’s Disease: a TMS-EEG Study

I. Maidan, Z. Katzir, M. Bouter, M. Gilat, J. Nonnekes, L. Avanzino, E. Pelosin, A. Mirelman (Tel Aviv, Israel)
Functional Belly Dancer Dyskinesia Associated with Abdominal Pain: A Case Series

M. Hildaria, A. Tiksnadi, F. Abdat, D. Tunjungsari (Jakarta, Indonesia)
Functional Connectivity Subtypes Predict Longitudinal Motor Progression and Gait Disturbance in Parkinson’s Disease

S. Wang, Y. Xiao, Y. Hou, C. Li, R. Ou, J. Lin, T. Yang, Q. Jiang, X. Zheng, J. Liu, H. Shang (chengdu, China)
Functional Dyskinesia in a Patient with Parkinson’s Disease: A Diagnostic and Therapeutic Challenge

V. Kotenev, V. Tkachenko, A. Nikitina (Moscow, Russian Federation)
Functional Improvement Following Early GPi-DBS for Moderate-Stage Atypical KMT2B Dystonia: A Case Report in a 13-Year-Old Girl

Z. Sclavont, V. Leclercq, C. Vilain, S. Schuind, F. Supiot, N. Deconinck, P. van Gyseghem (Brussels, Belgium)
Functional Intramuscular Stimulation for Pain in Parkinson’s Disease and Sporadic Amyotrophic Lateral Sclerosis: A Retrospective Case Series

C. Peterson, A. Ahn, K. Ahn, M. Might (Birmingham, USA)
Functional Movement Disorders in a Public Health System: Misdiagnosis, Diagnostic Delay, and Healthcare Utilization in 61 Patients

L. Tesolin (Bolzano, Italy)
Functional Movement Disorders in Older Adults in Latin America: A Narrative Literature Review

M. Bonilla-Arbeláez, M. Wongpaiboon, J. Urrea-Perez, A. Ramirez-Zamora, E. Urrea-Mendoza (Caldas, Colombia)
Functional Neurological Disorder And Anti-GAD65–Associated Autoimmune Neurological Disease: Diagnostic Overlap In A Retrospective Case Series

B. Talavera, M. García Huguet, Z. Yu, J. Patino, A. Lin, A. Espay (Cincinnati, USA)
Functional neurosurgery in Parkinson’s disease: Effects on quality of life.

P. Paez, G. Bartoli, J. Ziliani, M. Montiel (EL PALOMAR, Argentina)
FuRST 2.0, A Patient Reported Outcome (PRO) Measure of Functional Ability in Huntington’s Disease (HD): Getting Response Options Right

R. Fuller, M. Roche, N. Sinha, S. Sathe, C. Sampaio, G. Stebbins (Princeton, USA)
FUS R521S mutation causing levodopa responsive amyotrophic lateral sclerosis-Parkinson’s disease (ALS-PD).

R. Peh, EK. Tan, P. Kumar, MH. Yong, K. Narasimhalu (Singapore, Singapore)
Fusion Learning with Attention-VAE Imputation for Mixed-Reality Multisensor Screening of Parkinson’s Disease

J. Krzywdziak, J. Stępień, W. Szecówka, M. Dudek, M. żbik, M. Baran, N. Bozetine, J. Sikora, M. Wójcik-Pędziwiatr, M. Rudzińska-Bar, D. Hemmerling (Warsow, Poland)

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z